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Although there have been reports of the differentiation of mesenchymal stem cells and mouse
embryonic stem (ES) cells into steroid-producing cells, the differentiation of human ES/induced
pluripotent stem (iPS) cells into steroid-producing cells has not been reported. The purpose of our
present study was to establish a method for inducing differentiation of human ES/iPS cells into
steroid-producing cells. The first approach we tried was embryoid body formation and further
culture on adherent plates. The resultant differentiated cells expressed mRNA encoding the ste-
roidogenic enzymes steroidogenic acute regulatory protein, 3-hydroxysteroid dehydrogenase,
cytochrome P450-containing enzyme (CYP)-11A1, CYP17A1, and CYP19, and secreted progester-
onewas detected in the cell medium. However, expression of human chorionic gonadotropin was
also detected, suggesting the differentiated cells were trophoblast like. We next tried a multistep
approach. As a first step, human ES/iPS cells were induced to differentiate into the mesodermal
lineage. After 7 d of differentiation induced by 6-bromoindirubin-3-oxime (a glycogen synthase
kinase-3 inhibitor), thehumanES/iPS cells haddifferentiated into fetal liver kinase-1- andplatelet
derived growth factor receptor--expressing mesodermal lineage cells. As a second step, plasmid
DNA encoding steroidogenic factor-1, a master regulator of steroidogenesis, was introduced into
these mesodermal cells. The forced expression of steroidogenic factor-1 and subsequent addition
of 8-bromoadenosine 3,5-cyclic monophosphate induced the mesodermal cells to differentiate
into the steroidogenic cell lineage, and expression of CYP21A2 and CYP11B1, in addition to ste-
roidogenic acute regulatory protein, 3-hydroxysteroid dehydrogenase, CYP11A1, and CYP17A1,
was detected. Moreover, secreted cortisol was detected in the medium, but human chorionic
gonadotropin was not. These findings indicate that the steroid-producing cells obtained through
the described multistep method are not trophoblast like; instead, they exhibit characteristics of
adrenal cortical cells. (Endocrinology 153: 4336–4345, 2012)
Stemcells are gaining attention as promising tools in thefield of regenerative medicine and developmental bi-
ology especially after the establishment of human embry-
onic stem (ES) cells in 1998 (1) and human induced pluri-
potens stem (iPS) cells in 2007 (2). Human iPS cells are
considered to possess similar characteristics to human ES
cells (2). Because they overcome the immunological and eth-
ical problems associated with human ES cells, human iPS
cells represent a powerful new toolwithwhich to investigate
disease-specific disorders of organ development/differentia-
tion, and represent another potentially effective approach to
cell transplantation-based regenerative medicine.
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Among the classic endocrine cells, the differentiation of
pancreatic -cells from ES/iPS cells has been most inten-
sively investigated (3, 4). The differentiation of stem cells
into steroid-producing cells has also been investigated,
and in 1997 Crawford et al. reported that the forced ex-
pression of steroidogenic factor-1 (SF-1), a transcriptional
factor belonging to the nuclear receptor superfamily, di-
rectedmouseEScells into the steroidogenic cell lineage (5),
although the steroidogenic capacity of these cells was very
limited because progesterone was the only steroid hor-
mone produced in the presence of an exogenous substrate,
20-hydroxycholesterol. More recently several groups
have reported that both mouse and human mesenchymal
stem cells (MSC) can be induced to differentiate into ste-
roid-producing cells through forced expression of SF-1
and that the resultant steroid-producing cells produce a
wider variety of steroid hormones (6–9), but the MSC-
derived steroid-producing cells have not been well char-
acterized because there is no evidence that the steroid-
producing cells naturally develop from the MSC. In 2011
Yazawa et al. (10) reported a method for differentiating
mouse ES cells into steroid-producing cells through tetra-
cycline-controlled transcriptional activation of SF-1.
However, human ES cells possess a number of character-
istics distinct from those ofmouse ES cells, such as surface
antigens, leukemia inhibitory factor independency, and
long doubling time (11), and no investigation of steroid-
ogenic differentiation using human ES or iPS cells has yet
been reported.
Adrenal insufficiency, which is caused by Addison’s
disease, congenital adrenal hyperplasia, hypopituitar-
ism, and other diseases, is a condition in which the ad-
renal glands do not produce adequate amounts of the
steroid hormones cortisol, aldosterone, and adrenal an-
drogen (12). Hormone replacement therapy is currently
the best treatment strategy for steroid insufficiency (12,
13), and most of these patients, especially those with
adrenal insufficiency, require therapy for their entire
lives and are thus always at risk from side effects, which
sometimes can be life threatening (12). Therefore, an in-
novative therapy that could solve these problemswouldbe
desirable. Establishing a method for differentiating hu-
man ES/iPS cells into steroid-producing cells could poten-
tially lead to a cell therapy for adrenal insufficiency in the
foreseeable future. Moreover, through the use of compre-
hensive high-throughput screening of the actions of small
molecules during the differentiation of human ES/iPS cells
into steroidogenic cells, it may be possible to identify new
agents that promote the regeneration of steroidogenic or-
gans fromsomatic stemcells. In addition, it could alsohelp
in the elucidationof themolecularmechanismsunderlying
thedevelopment and thedifferentiationof the adrenal cor-
tex and the gonad. We previously characterized the pro-
cess of humanES/iPS cell differentiation into vascular cells
(14) and adipocytes (15). The purpose of our
present study was to establish a method for




Two human ES cell lines (H9 and KhES1) and
one human iPS cell line (201B7) were investigated.
The iPS 201B7 line was generated by introducing
four transcription factors (Oct3/4, Sox2, Klf4, and
c-Myc) into human skin fibroblasts. Undifferenti-
ated human ES and iPS cells were grown on mito-
mycin C-treated mouse embryonic fibroblast feed-
ers in primate ES medium (ReproCELL, Tokyo,
Japan) supplemented with 4 ng/ml recombinant hu-
man basic fibroblast growth factor (Wako Pure
Chemical Industries, Ltd., Osaka, Japan). Routine
maintenance of human ES cell cultures was per-
formed according to the protocol recommended by
Kyoto University (16). All research on human ES
cells was conducted in conformity with the Guide-
lines for Derivation and Utilization of Human Em-
bryonic StemCells (2009) published by theMinistry
of Education, Culture, Sports, Science, and Tech-
nology of Japan.
FIG. 1. RT-PCR analysis of the indicated cell lines (H9, KhES1, and B7) before
differentiation (undifferentiated), during EB formation (EB), and after 10 d of culture
on gelatin-coated dishes. Results obtained with human adrenal gland, testis, and
placenta are shown for comparison.
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Embryoid body formation
For embryoid body (EB) formation, human ES/iPS cell colo-
nies were digested with 1 mg/ml collagenase type IV (Gibco,
Carlsbad, CA) and plated onto nonadherent culture dishes, in
which they were allowed to aggregate in maintenance medium
[77%DMEM/F12medium, 20%knockout serum replacement,
1%nonessential amino acids, 1%penicillin/streptomycin, 2mM
L-glutamine, and 0.1 mM -mercaptoethanol] without basic fi-
broblast growth factor for 14 d. About 100 of the resultant EB
were lysed for RNA extraction. Also, about 40 of the resultant
EB were transferred to each well of 12-well plates coated with
gelatin. The transferred EBwere grown in maintenance medium
for further differentiation.
Mesodermal differentiation of human ES and iPS
cells
Mesodermal differentiation of human ES/iPS cells was con-
ducted as described previously with a little modification (17).
Briefly, undifferentiated human ES/iPS cells were detached using
PBS containing 1mg/ml collagenase type IV, 0.25% trypsin, and
20% knockout serum replacement, dissociated into small cell
FIG. 2. Immunocytochemical analysis of 3-HSD (A–C) and hCG (D–F) expression in the indicated cell lines (H9, KhES1, and B7) after 10 d of
culture on gelatin-coated dishes after EB formation.
TABLE 1. Hormone levels in medium conditioned by undifferentiated ES/iPS cells and differentiated cells obtained
via EB formation
Undifferentiated Differentiated
H9 KhES1 B7 H9 KhES1 B7
Progesterone (pg/ml) N.D. N.D. N.D. 4320  510 3450  1290 10800  2030
Corticosterone (pg/ml) N.D. N.D. N.D. N.D. N.D. N.D.
Cortisol (pg/ml) N.D. N.D. N.D. N.D. N.D. N.D.
Aldosterone (pg/ml) N.D. N.D. N.D. N.D. N.D. N.D.
DHEA (pg/ml) N.D. N.D. N.D. N.D. N.D. N.D.
Estradiol (pg/ml) N.D. N.D. N.D. 110  30 110  40 350  40
hCG (mIU/ml) N.D. N.D. N.D. 120  30 280  60 1300  110
Data are means  SEM of triplicate experiments. Differentiated cells were cultured on gelatin-coated dishes for 10 d after EB formation on
nonadherent dishes. N.D., Not detectable.
4338 Sonoyama et al. Steroidogenic Differentiation of ESC/iPSC Endocrinology, September 2012, 153(9):4336–4345
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 05 March 2014. at 18:09 For personal use only. No other uses without permission. . All rights reserved.
clumps, and plated onto type I collagen-coated dishes. The cells
were then cultured for 1 d in maintenance medium, after which
the medium was changed to maintenance medium containing 5
M 6-bromoindirubin-3-oxime (BIO), a glycogen synthase ki-
nase-3 (GSK-3) inhibitor, and the cells were cultured for 3 d.
Themediumwas then changed tomaintenancemedium, and the
cells were cultured for an additional 3 d.
Flow cytometry
Cells were detached and harvested using 0.05% trypsin/
EDTA (Gibco) and were neutralized with DMEM containing
10% fetal bovine serum for 30 min at 37 C. The cells were then
washed twice and stained with the following monoclonal anti-
bodies: fluorescein isothiocyanate-conjugated antihuman tumor
rejection antigen 1–60 (TRA 1–60) (BD Biosciences, Franklin
Lakes, NJ), phycoerythrin-conjugated antihuman platelet-de-
rived growth factor receptor- (PDGFR) (BDBiosciences), and
Alexa Flour 647 (Invitrogen, Carlsbad, CA)-labeled anti-fetal
liver kinase-1 (Flk1). After the antibody reaction, the cells were
washed twice and filtered through a nylon screen (pore size, 35
m; BD Biosciences). Flow cytometric analysis and cell sorting
were performed using fluorescence-activated cell sorter Aria II
(BD Biosciences), following the manufacturer’s instructions.
DNA transfection
About 1 106 cells were transfected with 5 g of expression
plasmid encoding SF-1 driven by the cytomegalovirus promoter
(pCMFlag-hsNR5A1, obtained from Riken BRC, Saitama, Ja-
pan). The transfection was accomplished using Nucleofector
(Lonza, Gaithersburg, MD) according to the manufacturer’s in-
structions. Nucleofector technology is a nonviral approach to
transferring nucleic acids into cells and is based on themethod of
electroporation.The transfection efficiencywasabout40–60%.
RT-PCR and quantitative real-time PCR
Total RNAwas extracted using an RNeasy minikit (QIAGEN,
Venlo, The Netherlands) according to the manufacturer’s instruc-
tions. Aliquots of total RNA were then reverse transcribed into
cDNAusing PrimeScript reverse transcriptase reagent (TakaraBio,
Shiga, Japan); the reactionwas carried out at 42C for 15min and
terminated by heating at 70 C for 2 min. For RT-PCR, 1 g of
total RNA was reverse transcribed, and one 50th of the re-
action mixture was subjected to PCR using a thermal cycler.
The reaction protocol entailed denaturation at 94C for 30 sec,
annealing at 58 C for 30 sec, and extension at 72 C for 30 sec.
Ten microliters of the PCR products were electrophoresed on
a 1.5% agarose gel and then visualized by ethidium bromide
staining. Levels of mRNA expression were quantified by real-
time RT-PCR using an ABI PRISM 7300 sequence detection
system (Applied Biosystems, Carlsbad, CA) and a SYBR Pre-
mix Ex Taq kit (Takara Bio). To calculate the copy number of
each mRNA, standard curves were generated using synthe-
sized oligo DNA fragments containing the PCR amplicon re-
gion (Sigma-Aldrich Japan, Tokyo, Japan). The PCR protocol
entailed an initial denaturation at 95 C for 10 min, followed
by 40 cycles of 95 C for 10 sec and 60 C for 31 sec. The levels
of each mRNA were normalized with that of a housekeeping
gene, -actin.
Western blot analysis
For protein extraction, cultured cells were homogenized in
ice-cold cell lysis buffer (Cell Signaling Technology, Beverly,
MA) containing protease inhibitor cocktails (RocheApplied Sci-
ence, Indianapolis, IN).After centrifugation at 15,000 g for 10
min, lysates were separated by SDS-PAGE, followed by electro-
phoretic transfer to an Immobilion-P membrane (Millipore, Bis-
ley, UK). Immunoblotting was performed with the following
primary antibodies: -catenin (Abcam, Cambridge, UK) and
-actin (Abcam). The immunoblot was incubated with horse-
radish peroxidase-conjugated secondary antibody, and the
chemiluminescent signals were developed by ECL-Prime (Am-
ersham, Aylesbury, UK). The signals were quantified with an
ImageQuant LAS-4010 system (GE Healthcare, Tokyo, Japan).
Immunocytochemistry
For immunocytochemical analyses, cells were fixed in either
PBS containing 4% paraformaldehyde for 10 min at room tem-
perature or 70% ethanol for 30 min at 4 C. After washing the
fixed cells with PBS, theywere incubatedwithmouse antihuman
3-hydroxyl steroid dehydrogenase (3-HSD) antibody (1:100;
Santa Cruz Biotechnology, Santa Cruz, CA) and mouse antihu-
man chorionic gonadotropin (hCG) antibody (1:500; Dako,
Glostrup, Denmark). Following the primary antibody reaction,
the cells were treated according to the manufacturer’s instruc-
FIG. 3. Schematic flow diagram of the multistep method. FBS, Fetal
bovine serum.
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tions with a Dako Envision kit, mouse/horseradish peroxidase
(Dako), which is a peroxidase-labeled polymer kit conjugated to
goat antimouse immunoglobulin. Thereafter the cells were
stained with 3,3-diaminobenzidine (DAB) using DAB Liquid
(Dako). Finally, the nucleiwere stainedwith hematoxylin (Muto
Pure Chemicals, Tokyo, Japan).
Steroid hormone measurement
Steroid hormones and hCG in conditioned cell medium were
measured 24 h after the prior medium change. Levels of proges-
terone, corticosterone, cortisol, aldosterone, dehydroepiandro-
sterone (DHEA), and estradiol in the mediumwere all measured
using commercially available enzyme immunoassay kits (Cay-
man Chemical, Ann Arbor,MI). hCG levels were similarly mea-
sured using a commercially available enzyme immunoassay kit
(Cayman Chemical).
Statistical analysis
All data are expressed as the means  SEM. Comparison of
means between two groups was done using Student’s t test. Val-
ues of P  0.05 were considered statistically significant.
Results
Induction of steroid-producing cells via EB
formation
An EB is a three-dimensional aggregate of ES or iPS cells
formed in suspension culture; it is thought tomimic some of
the early stages of embryonic development and to differen-
tiate into the three primary germ layers: endoderm, meso-
derm, and ectoderm. Human ES cells have been shown to
differentiate into many cell types, including -cells (18),
hepatocytes (19), adipocytes (15), cardiomyocytes (20),
bone (21), and neurons (22) via EB formation. For that rea-
son, we initially tried to use the EB formation approach to
induce differentiation of human ES/iPS cells into steroido-
genic cells. RT-PCR and quantitative real-time RT-PCR
analyses showed that, in undifferentiated human ES or iPS
cells, mRNA expression of steroidogenic genes were not
detectable or hardly detectable except steroidogenic
acute regulatory protein (StAR) (Fig. 1 and Supplemen-
tal Fig. 1, published on The Endocrine
Society’s Journals Online web site at
http://endo.endojournals.org). After
EB formation during 14 d of suspen-
sion culture, the cells expressedmRNA
encoding the steroidogenic enzymes
StAR, cytochrome P450-containing en-
zyme (CYP)-11A1, 3-hydroxysteroid
dehydrogenase (HSD3B), CYP17A1,
and CYP19, but they did not express
CYP21A2, CYP11B1, or CYP11B2
mRNA, whose translation products are
required for the synthesis of both adre-
nocorticalandgonadal steroidhormones
(Fig. 1 and Supplemental Fig. 1).
The EBwere next plated on gelatin-
coated dishes and cultured for an ad-
ditional 10 d, which up-regulated the
expression of StAR, CYP11A1, HSD3B,
CYP17A1, and CYP19 mRNA. How-
ever, expression of CYP21A2, CYP11B1,
and CYP11B2 mRNA was still not de-
tected (Fig.1andSupplementalFig.1). In
immunocytochemical analyses, some of
the cells stained positively for 3-HSD
(Fig. 2). The 3-HSD-positive cells were
present on the periphery of the EB and
had large amounts of cytoplasm and a
largenucleus, and someweremultinucle-
ate (Fig. 2).Whenwe thenmeasured ste-
roidhormones secreted into themedium,
we found that the medium contained
progesterone and estradiol but not corti-
FIG. 4. Mesodermal differentiation of human ES/iPS cells using BIO. A, Flow cytometric
analysis of the indicated cell lines after treatment with BIO. TRA1–60-negative, differentiated
cells were sorted, and expression of the mesodermal cell surface markers Flk1 and PDGFR
was evaluated. B, RT-PCR analysis of the indicated cell lines before differentiation
(undifferentiated), after differentiation induced without BIO, and after differentiation induced
with BIO. C, Western blot analysis for -catenin and -actin of the indicated cell lines before
differentiation (undifferentiated), after differentiation induced without BIO, and after
differentiation induced with BIO.
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sol, corticosterone, aldosterone, or DHEA (Table 1). These
results indicate that EB formation induced human ES/iPS
cells to become steroidogenic but did not induce their differ-
entiation into the adrenocortical lineage.
One major source of progesterone is trophoblasts.
We therefore next measured hCG secretion from the
cells because hCG production is specific to tropho-
blasts.We found that the conditionedmedium also con-
tained hCG (Table 1); moreover, immunocytochemical
analysis showed that the differentiated cells included hCG-
positive cells, which appeared morphologically identical to
the 3-HSD-positive cells (Fig. 2). This indicated that the
steroidogenic cells obtained via EB formation were tropho-
blast-like cells, not adrenocortical lineage cells.
Induction of steroid-producing cells using the
multistep method
To differentiate human ES/iPS cells into steroid-pro-
ducing cells that are not trophoblast like but instead ex-
hibit the characteristics of adrenal cortical cells, we used
the multistep method shown schemat-
ically in Fig. 3. The adrenal cortex
develops from the adrenogenital pri-
modium, which originates from meso-
derm. Therefore, as a first step, human
ES/iPS cells were induced to differenti-
ate into themesodermal lineage cells us-
ing BIO, a GSK-3 inhibitor that acti-
vates the Wnt signaling pathway (Fig.
3). Then, as a second step, the meso-
dermal cells were transfected with
plasmid DNA encoding SF-1, a mas-
ter regulator of the differentiation/devel-
opment of steroid-producing cells, and
thetransfectantswerethenplatedontype
I collagen-coated dishes and further dif-
ferentiation was induced under the addi-
tion of 8-bromoadenosine 3,5-cyclic
monophosphate (8-Br-cAMP; a mem-
brane-permeable cAMP analog) (Fig. 3)
because cAMP is known to induce ste-
roidogenesis in a number of steroido-
genic cell lines.
In undifferentiated human ES/iPS
cells, mRNA expression of PDGFR or
steroidogenic enzymes were not detect-
able or hardly detectable (Figs. 1 and
Fig. 4 and Supplemental Fig. 2), al-
though slight expression of Flk1 was
detected. After 7 d of differentiation
with 5 M BIO, flow cytometric anal-
ysis revealed that TRA1–60-negative
non-ES/iPS cells had appeared, and
these cells were positive for the meso-
dermal markers Flk1 and PDGFR
(Fig. 4). Also, these cells had higher
levels of -catenin, indicating the activa-
tion of canonicalWnt signaling pathway
(Fig. 4). Then the TRA1–60-negative
cellswere sortedby flowcytometry to re-
move undifferentiated cells, and RT-
PCR and quantitative real-timeRT-PCR
FIG. 5. Differentiation of human ES/iPS cells using the multistep method. A, RT-PCR analysis of
the indicated cell lines before SF-1 transfection (mesoderm), cultured with 8-Br-cAMP without SF-
1 transfection [SF-1()cAMP()], after SF-1 transfection followed by culture without 8-Br-cAMP
[SF-1()cAMP()] and after SF-1 transfection followed by culture with 8-Br-cAMP [SF-
1()cAMP()]. Results obtained with human adrenal gland, testis, and placenta are shown for
comparison. B and C, Immunocytochemical analysis of 3-HSD (B) and hCG (C) expression in the
indicated cell lines after SF-1 transfection followed by 7 d of culture with 8-Br-cAMP.
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analyses of the sorted cells confirmed that they expressed
Flk1 and PDGFR mRNA as well as mRNA encoding the
intermediate mesodermal marker odd-skipped related 1
(Osr1) (Fig. 4). RT-PCRandquantitative real-timeRT-PCR
analyses of the sorted cells also revealed that the mRNA ex-
pressionof steroidogenic geneswerenotdetectableorhardly
detectable (Fig. 5 and Supplemental Fig. 3).
Themesoderm lineage cells, which were sorted by flow
cytometry, were then replated on type I collagen-coated
dishes and cultured for 3–5 d in DMEM containing 10%
fetal bovine serum, after which theywere transfectedwith
an expression plasmid encoding SF-1 driven by the cyto-
megalovirus promoter. The transfectants were then cul-
tured in DMEM containing 10% fetal bovine serum and
1mM8-Br-cAMP.After 7 d of culture, RT-PCRandquan-
titative real-time RT-PCR analysis revealed the mRNA
expression of the steroidogenic enzymes CYP21A1 and
CYP11B1 as well as StAR, CYP11A1, HSD3B, and
CYP17A1 (Fig. 5 and Supplemental Fig. 3). Low levels of
mRNA expression of these steroidogenic enzymes were
also detected in cells cultured in the absence 8-Br-cAMP
(Fig. 5 and Supplemental Fig. 3). In addition, measure-
ment of hormones secreted into the medium during 7 d of
culture with 8-Br-cAMP revealed the presence of proges-
terone, corticosterone, and cortisol but not hCG(Table 2).
In immunocytochemical analyses, the differentiated cells
stained positively for 3-HSD (Fig. 5) but were negative
for hCG (Fig. 5). These results indicated that the steroid-
ogenic cells obtained using themultistepmethodwere not
trophoblast like but were adrenocortical lineage cells.
Moreover, real-time RT-PCR analysis showed that the
levels of CYP11A1, HSD3B, and CYP17A1mRNA in the
cells after 14 d of culture with 8-Br-cAMPwere not lower
than the levels in the cells cultured with 8-Br-cAMP for
only 7 d (Fig. 6).
Discussion
In this study,wedemonstrated that humanES/iPS cells can
be differentiated into steroid-producing cells by first in-
ducing them to differentiate into the mesodermal lineage
and then introducing SF-1. The steroidogenic cells thus
obtained expressed mRNA encoding adrenal cortical or
gonad-specific steroidogenic enzymes, such as CYP17A1,
CYP21A2, andCYP11B1andproduced steroidhormones
such as progesterone, corticosterone, and cortisol.
We first assessedwhether human ES/iPS cells could dif-
ferentiate into steroidogenic cells via EB formation. After
EB formation in suspension and further culture on gelatin-
coated dishes, the cells spontaneously differentiated into
steroidogenic cells that expressed StAR, CYP11A1,
HSD3B, and CYP17A1 mRNA and secreted progester-
one. However, these cells also expressed hCG, which is
specific to trophoblasts. Consequently, we considered the
steroidogenic cells obtained via EB formation to be tro-
phoblast like. This finding is consistent with the earlier
report by Gerami-Naini et al. (23), who showed that hu-
man ES cells can spontaneously differentiate into tropho-
blast-like cells via EB formation
In the present study, we used theGSK-3 inhibitor BIO
to induce differentiation of human ES/iPS cells into the
mesodermal lineage. GSK-3 is a serine/threonine kinase
that phosphorylates and promotes the degradation of
-catenin.Wnt signaling functionsby regulating the trans-
location of -catenin to the nucleus. GSK-3 inhibitors,
including BIO, induce the accumulation of -catenin (24,
25), and the activation of the canonical Wnt/-catenin
signaling pathway in ES cells results in mesodermal dif-
ferentiation (24–27). Moreover, knockout mice deficient
in -catenin die in utero due to a complete lackmesoderm
(28). As shown in this study, human ES/iPS cells treated
with BIO, in which the canonical Wnt signaling pathway
was activated, expressed mesodermal markers, including
TABLE 2. Hormone levels in medium conditioned by undifferentiated ES/iPS cells and differentiated cells obtained
using a multistep method
Undifferentiated Differentiated
H9 KhES1 B7 H9 KhES1 B7
Progesterone (pg/ml) N.D. N.D. N.D. 1730  460 3080  1180 2480  590
Corticosterone (pg/ml) N.D. N.D. N.D. 460  57 605  55 661  59
Cortisol (pg/ml) N.D. N.D. N.D. 10510  1530 10030  1650 8540  820
Aldosterone (pg/ml) N.D. N.D. N.D. N.D. N.D. N.D.
DHEA (pg/ml) N.D. N.D. N.D. N.D. N.D. N.D.
Estradiol (pg/ml) N.D. N.D. N.D. N.D. N.D. N.D.
hCG (mIU/ml) N.D. N.D. N.D. N.D. N.D. N.D.
Data are means  SEM of triplicate experiments. Differentiated cells were cultured with 8-Br-cAMP for 7 d after transfection of SF-1 into
mesodermal lineage cells derived from human ES/iPS cells. N.D., Not detectable.
4342 Sonoyama et al. Steroidogenic Differentiation of ESC/iPSC Endocrinology, September 2012, 153(9):4336–4345
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 05 March 2014. at 18:09 For personal use only. No other uses without permission. . All rights reserved.
Flk1 and PDGFR (29). In addition, themesodermal cells
expressed mRNA encoding the intermediate mesodermal
marker odd-skipped related 1 (Osr1), which is known to
be essential for development of the heart and intermediate
mesoderm, including the adrenal cortex (30). However,
the mesodermal cells that we induced from human ES/iPS
cells through Wnt/-catenin activation by BIO did not
expressmRNAencoding the steroidogenic enzymes them-
selves.We therefore introduced SF-1 into the mesodermal
cells as a next step.
SF-1 is an orphan nuclear receptor that belongs to the
NR5Asubfamilyof thenuclear receptor superfamily. SF-1
is essential for sexual differentiation and formation of the
primary steroidogenic tissues (31); SF-1 knockout mice
completely lack adrenal glands and gonads and die soon
after birth (32). In humans, heterozygous SF-1 mutations
can cause XY sex reversal (i.e. testicular failure), ovarian
failure, and occasionally adrenal insufficiency (33).
In an earlier study, Crawford et al. (5) showed that
exogenous expression of SF-1 directedmouse ES cells into
the steroidogenic lineage, although the steroidogenic ca-
pacity of the differentiated cells was very limited. Recently
two other groups reported that exogenous expression of
SF-1 induced differentiation of mouse and human MSC
into steroidogenic cells that produced a variety of steroid
hormones in addition to progesterone (6–9). On the other
hand, forced expression of SF-1 in already differentiated
cells, such as preadipocytes, fibroblasts, and human em-
bryonic kidney 293 cells, did not induce their further dif-
ferentiation into the steroidogenic lineage (6). Moreover,
Gondo et al. (6) reported that steroid hormoneproduction
was observed for more than 112 d when bone marrow-
derivedMSCwere transfected with SF-1 by means of an
adenoviral vector (mean half-life is usually 2–3 wk).
These findings indicated that SF-1 can serve as a differ-
entiating factor for the steroidogenic differentiation of
multipotent stem cells. In the present study, we used an
expression plasmid encoding SF-1 in part because tran-
siently increased expression of SF-1 is reportedly crucial
for differentiation of the adrenal cortex and gonads
(34). Another reason was that persistently elevated lev-
els of SF-1 are reportedly associated with adrenal tu-
morigenesis (35), which would be an obstacle to clinical
application. Our study showed that transiently ex-
pressed SF-1 functioned as a differentiating factor in the
steroidogenic differentiation of mesodermal cells and
that the expression of steroidogenic enzymes persisted
for much longer than the half-life of the plasmid (mean
half-life is usually 2–3 d).
One of the limitations of our study is that the differenti-
ated cells do not proliferate as well as undifferentiated cells
do, making it difficult to obtain large numbers of cells. An-
other limitation is that their in vivo functionality was not
evaluated. Clearly, further studies will be required before
clinical application of the steroidogenic cellswe developed is
possible.
FIG. 6. Real-time RT-PCR analysis of CYP11A1 (A), HSD3B (B), and
CYP17A1 (C) mRNA expression in the indicated cell lines after 7 or
14 d of culture after SF-1 transfection. The copy number of mRNA of
each steroidogenic enzymes was normalized with that of a
housekeeping gene, -actin. Data are means and SEM of three triplicate
experiments.
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In conclusion, we showed in this study that human
ES/iPS cells can be induced to differentiate into meso-
dermal lineage cells using a GSK-3 inhibitor and that
subsequent introduction of SF-1 can induce the meso-
dermal lineage cells to differentiate into steroid-pro-
ducing cells with the characteristics of adrenal cortical
cells for the first time to our knowledge. Although fur-
ther studies are required, our method will open a new
avenue to the elucidation of the molecular mechanisms
underlying the development/differentiation of the ad-
renal cortex and to the future possibility of cell therapies
for patients with adrenal insufficiency.
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